Manufacturer of advanced clinical diagnostic technologies
OPTI Medical Systems, Inc. specializes in the design and manufacturing of point-of-care and laboratory diagnostic solutions. OPTI Medical Systems leverages advanced technologies to develop reliable, cost-effective products that combine accuracy with convenience, ease of use, and clinical flexibility to support infectious disease diagnostics as well as point-of-care blood gas and electrolyte analysis using optical fluorescence technology.
COVID-19 response
OPTI SARS-CoV-2 RNA PCR Test Kit receives US FDA Emergency Use Authorization
The test kit is based on real-time reverse transcription polymerase chain reaction (RT-PCR), which provides detection of the viral RNA in the sample. The OPTI SARS-CoV-2 RT-PCR test kit detects human RNase P as an internal sample control and endogenous nucleic acid to control for sample addition, extraction, and amplification. The test provides results in approximately 2–3.5 hours and has been validated on commonly available qPCR instruments.
IDEXX investor resources
1-207-556-8155
Fax 1-207-556-4427
[email protected]
Contact us
- U.S. Main Number: 1-770-510-4444
- Europe Main Number: +800 727 43399
- 24/7 Technical Support: 1-800-490-6784
- Routine inquiries contact form
- Technical support request form